VaxcytePCVX +5.23%34 Pretax Margin % is % as of Mar. 2026. GuruFocus rates PCVX with a GF Score™ of 34/100. The stock has 2 warning signs investors should review. Among 946 Biotechnology companies, Vaxcyte ranks worse than 105708.14% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Vaxcyte's Pre-Tax Income for the
three
months ended in Mar. 2026 was $-320.62 Mil. Vaxcyte's Revenue for the
three
months ended in Mar. 2026 was $0.00 Mil. Therefore, Vaxcyte's pretax margin for the quarter that ended in Mar. 2026 was %.
The historical rank and industry rank for Vaxcyte's Pretax Margin % or its related term are showing as below:
PCVX's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -90.5 * Ranked among companies with meaningful Pretax Margin % only.
Vaxcyte (NAS:PCVX) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Vaxcyte Pretax Margin % Related Terms
Vaxcyte Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Vaxcyte's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PCVX vs CORT, IBRX, HALO: Pretax Margin % Comparison
For the Biotechnology subindustry, Vaxcyte's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vaxcyte Pretax Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Vaxcyte's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Vaxcyte's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vaxcyte (PCVX) has a Pretax Margin % of % as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Vaxcyte and its competitors. According to the industry distribution chart, Vaxcyte ranks #999999 out of 946 companies in the Biotechnology industry.
Is Vaxcyte's Pretax Margin % too high?
Vaxcyte's current Pretax Margin % is %. Based on the distribution chart, Vaxcyte ranks #999999 out of 946 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Vaxcyte has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Vaxcyte's Pretax Margin % compare to CORT and IBRX?
According to the Biotechnology industry distribution chart, Vaxcyte ranks #999999 out of 946 companies for Pretax Margin %. This places Vaxcyte in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Vaxcyte and its competitors. Vaxcyte's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaxcyte stock overvalued right now?
Vaxcyte (PCVX) has a current Pretax Margin % of %. The current Pretax Margin % is %. Vaxcyte's overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Vaxcyte (PCVX), the current Pretax Margin % is % as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
34GF Score
Get the complete analysis for PCVX
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PCVX has been successfully added to your 
